TCL Archive New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years October 26, 2012
TCL Archive HOP Development Proceeding Guidelines For New, Revision Of Existing Control Grants Being Written July 24, 1981
TCL Archive Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate March 25, 2011